COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01450488
Brief Title: Masitinib in Primary Progressive Multiple Sclerosis or Relapse-free Secondary Progressive Multiple Sclerosis

First Submitted : October 6, 2011
First Submitted that Met QC Criteria : October 10, 2011
First Posted : October 12, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : December 8, 2018
Last Update Posted : December 11, 2018